Stockpiling active pharmaceutical ingredients for critical drugs is prudent. However, domestic production of prioritized auxiliary chemicals must be part of strategy.
The new site in Hopewell will provide scalable, end-to-end adeno-associated virus production capabilities in a single U.S.-based location, according to the company.
